CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, welcomes The Biden Cancer Initiative to the Strategic Alliance Partnership (SAP) program. The partners will collaborate to promote patient education and administration policies for cancer prevention, detection, diagnosis, research and care approaches.

“It’s an honor to team up with The Biden Cancer Initiative,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of CURE Media Group. “Through this partnership, we look forward to providing key resources to the community on early stages of cancer diagnoses and cancer prevention.”

Founded by former U.S. vice president and second lady (2009-2017), Joe Biden and Dr. Jill Biden, The Biden Cancer Initiative, builds on the Cancer MoonShot program’s ultimate goal to eliminate cancer. This nonprofit organization focuses on reducing disparities in patient outcomes by easing the treatment navigation process of cancer patients and caregivers. Established to overcome the lack of cohesive, comprehensive and timely approach to cancer prevention, detection, diagnosis, research and care, the foundation serves as a guiding force for the cancer community. Additionally, it instills a sense of urgency into cancer research and care systems and redesigning the ways government, academia, private sector and nonprofit organizations join forces to fight cancer.

On Friday, September 21, the Bidens are hosting a national Biden Cancer Community Summit in Washington, D.C. The summit will focus on the patient’s journey from prevention through a cancer diagnosis, treatment through survivorship, and determine what we must do to accelerate progress. As part of this joint effort, The Biden Cancer Initiative will be able to share valuable content through CURE® magazine and its sister publication, American Journal of Managed Care®, where readers will have access to unprecedented content including latest research, interviews and articles that can help cancer patients and policymakers stay informed. The SAP program is designed to facilitate an open exchange of information among trusted peers, the goal of which is to improve patient care.

For more information about the Strategic Alliance Partnership Program, visit https://www.curetoday.com/advocacy/partners.

Articles

Sister publication American Journal of Managed Care® will also be a part of this collaboration

CURE Media Group Expands Strategic Alliance Partnership Program with The Biden Cancer Initiative

CRANBURY, N.J.--(BUSINESS WIRE)--CURE® magazine, the nation’s leading consumer digital and print media enterprise focused on patients with cancer, was recently named a finalist in four categories in the Folio: Eddie and Ozzie Awards, the most prestigious and most inclusive awards program in the publishing community.

“It is a tremendous honor that CURE® magazine has been recognized as a finalist in the Folio: Eddie and Ozzie Awards,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of CURE Media Group. “This recognition clearly demonstrates how hard the whole team works to furthering our mission in providing valuable information to patients, caregivers and survivors of cancer.”

Consumer column/blog: I Still Am by Tracy Ahrens

Consumer podcast: A Candid Conversation with Patrick Dempsey by Katie Kosko

Consumer health, single article: Flat, But Not Flattened by Stacy Verner

Consumer (circulation greater than 100 to 500) feature design: Cancer Under Cover by Ray Pelesko (Winter 2018)

Each year, over 2,000 entries in the Folio: Eddie and Ozzie Awards compete across 200 categories that recognize excellence in editorial and design. This year, winners and honorable mentions will be announced during a celebratory gala Tuesday, October 9, from 5:30 to 8:30 p.m. at the New York Hilton Midtown in New York City.

For more information, visit www.foliomag.com/go/2018-eddie-and-ozzie-awards.

CURE Magazine Named 2018 Folio: Eddie & Ozzie Award Finalist in Four Categories

 Media Group, the nation’s leading digital and print media enterprise focused on patients with cancer, has opened nominations for its 2019 Extraordinary Healer® Award for Oncology Nursing. This yearly honor recognizes oncology nurses who have made great strides in the field of oncology or who have demonstrated commendable compassion in patient care. 

“We are excited to be accepting nominations for this year’s Extraordinary Healer® Award for Oncology Nursing and thrilled to recognize another exceptional oncology nurse who makes a real difference in the care of their patients,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of 

Nominations will be accepted through Jan. 1 and can be submitted by current and former patients, caregivers, or peers in the form of a 700- to 1,000-word essay that should reflect the candidate’s outstanding contributions to the field of oncology or in a patient’s life. The selection committee will choose three finalists who will be honored at a gala reception held in conjunction with the Oncology Nursing Society’s 44th Annual Congress, which will take place in April 2019 in Anaheim, California. One nurse ultimately will be recognized with the 2019 Extraordinary Healer® Award for Oncology Nursing.

For more information and to submit a nomination online, visit https://www.curetoday.com/extraordinaryhealer.

CURE Media Group Seeks Nominations for the 2019 Extraordinary Healer Award for Oncology Nursing

® magazine, the nation’s leading consumer digital and print media enterprise focused on patients with cancer, published its most recent Rare Cancers issue, announced Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of 

In making the announcement, Michael J. Hennessy, Jr said, “Our Rare Cancers issue hits close to home, as we are the leading resource for cancer updates, research and education within the cancer community. It is our mission to continue our efforts in providing the most up-to-date research and studies to cancer patients, survivors and their caregivers.”

Although the oncology field continues to advance in many ways, studying a rare cancer — defined by the American Cancer Society as fewer than six cases per 100,000 people each year &mdash; presents a challenge due to the rarity of these diseases.

In this issue, CURE® focuses its cover story, Advances and Combinations Raise Sights on Uveal Melanoma, on the clinical trials that seek to discover new ways to attack cancer of the eye, limit metastasis and prevent recurrence of the disease. Two patients share their very different journeys with uveal melanoma — one woman developing metastasis to her liver and brain &mdash; and how they are doing today.

Turning the Tide. Innovations in drug development, surgery, radiation and clinical trials have investigators hard at work in glioblastoma.

Waldenstrom Macroglobulinemia: The Discovery and What Lies Ahead. This incurable rare cancer of the lymphatic system has seen improvements, but what is the best strategy for treating patients with the disease?

Training Through Treatments: Pro Runner Doesn’t Let Rare Cancer Slow Her Down. After receiving a diagnosis of adenoid cystic carcinoma, Gabriele Grunewald wanted to help others and founded Brave Like Gabe.

In addition, the magazine offers news and updates within the rare cancer space, from a Food and Drug approval in thyroid cancer to clinical trials in pediatric cancers and new targeted therapies for a mantle cell lymphoma prognosis.

To read more from the Rare Cancers Special Issue, visit curetoday.com.

CURE Magazine Releases Its Rare Cancers Specialty Issue

 Media Group, the nation’s leading digital and print media enterprise focused on cancer patients, is proud to announce that Scott Hamilton, Olympic champion, author and cancer survivor, will be the guest speaker for the 6thAnnual MPN Heroes® recognition ceremony. The event honors individuals or organizations that have made a difference in the field of blood cancers known as myeloproliferative neoplasms (MPNs). This year’s program will take place on Friday, November 30, at the Hard Rock Hotel San Diego.

“We are thrilled to have Scott Hamilton as the guest speaker for this celebration,” said Michael J. Hennessy Jr., President of MJH Associates Inc., parent company of 

 Media Group. “As a cancer survivor and longtime advocate for cancer research and education, Scott’s values are perfectly aligned with the core principles of the MPN Heroes recognition program. Together, we look forward to celebrating the accomplishments of these heroes at the MPN Heroes recognition ceremony.”

Inspired by his own journey with testicular cancer and pituitary brain tumors, and the loss of his mother to cancer, Hamilton launched the Scott Hamilton CARES (Cancer Alliance for Research, Education and Survivorship) Foundation. This nonprofit organization provides education, supports research and hosts survivorship programs for patients and caregivers, and works to fund innovative therapies and treatment. Hamilton serves on the board of directors of the Provision Center for Proton Therapy in Knoxville, Tennessee.

The MPN Heroes Recognition Program is made possible by the generous support of Incyte Corporation, a global biopharmaceutical company that discovers and develops novel medicines to meet serious unmet medical needs in oncology and other diseases. The program honors those who are empowering patients with MPNs and making a difference in the MPN community. The honorees are nominated by patients and caregivers for their extraordinary contributions and dedication.

To reserve a seat at the event, visit https://www.curetoday.com/mpnheroes.

CURE Media Group Announces Scott Hamilton as Guest Speaker at the 2018 MPN Heroes Recognition Ceremony

® magazine, the nation’s leading consumer digital and print media enterprise focusing on patients with cancer, will be hosting its monthly TweetChat on Thursday, July 26, at 1 p.m. EDT, for readers to ask questions and to facilitate discussions about the role of cancer caregivers.

® welcomes all patients and their loved ones, as well as health care professionals, advocates and nonprofit organizations to join the chat by using the hashtag #CureConnect. The below highlights topics of discussion during the TweetChat:

For more information, visit https://www.curetoday.com or find us on Twitter (@cure_magazine) or on Facebook (@curemagazine).

 Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and 

® magazine, which reaches over 1 million readers, as well as the dynamic website for oncology nurses, OncNursingNews.com, and its companion, Oncology Nursing News® magazine. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive® (http://www.www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com.

CURE Magazine to Host #CureConnect TweetChat on Caregivers

CRANBURY, N.J.--(BUSINESS WIRE)--As a part of a fundraising effort by Moving Mountains for Multiple Myeloma (MM4MM), 15 individuals will take on a challenging hike through Iceland from Aug. 8 to 12. MM4MM is a joint initiative between the Multiple Myeloma Research Foundation, CURE Media Group and Celgene. The upcoming climb includes patients, caregivers, team members from the organizing partners and a myeloma doctor.

“As a patient founded organization, the MMRF stands together with those who are battling multiple myeloma — patients, families, physicians, researchers, and our pharmaceutical partners. This team represents a microcosm of that myeloma community and demonstrates that together, we can collaborate with ever increasing momentum towards a cure”, said Paul Giusti, CEO of the Multiple Myeloma Research Foundation. “We are thrilled to enter the third year of this inspiring program and to have Celgene join us in this effort to raise awareness and critical funds to continue our mission.” Called Fire and Ice, the hike will take the participants through geologic marvels including volcanoes, glaciers, geysers, hot springs, waterfalls and mountains. The proceeds will benefit the foundation’s life-changing efforts to further the development of multiple myeloma treatments. The organization has raised more than $2 million through six completed expeditions.”

The team includes five individuals who are living with multiple myeloma:

Jen Phlieger Ansier, 31, of Austin, Texas, received a diagnosis of multiple myeloma after her general physician found unusual lab results during a routine physical. Soon after, she started therapy and then received an autologous stem cell transplant in February 2007. A second transplant was needed in 2011. Since then, she has been in remission. Though she does not consider herself an endurance athlete, Ansier said, she is excited to challenge herself with the strenuous hike and hopes to inspire other young patients who are battling myeloma.

Rich Appelbaum, 64, of Oceanside, New York, received his diagnosis of multiple myeloma in 2016. He believes that his years as a competitive wrestler more than 40 years ago prepared him for this diagnosis and this hike. Keeping the wrestling mantra “Never, ever quit!” in mind, Applebaum said, he is ready to take on this challenge

Barbara, McCarrick, 59, of Pleasanton, California, received her diagnosis in 2009. She responded well to treatment that included tandem stem cell transplants but relapsed in 2013. She is now in remission and said she is eager to take on Fire and Ice to benefit the Multiple Myeloma Research Foundation. “With research, clinical trials and new treatments, I will, hopefully, have a long remission and soon, a cure,” she said.

Brian Smith, 35, of Bremerton, Washington, experienced severe neck and back pain in 2016. After X-rays and other tests revealed myeloma, Smith underwent a stem cell transplant and is now in remission. “I have refused to let this disease define me,” he said. “I have worked hard to live my life as normally as I can and continue to do the things that I love.” Trekking the mountains and valleys of Iceland is in line with this philosophy, he said.

Emily Schottman, 48, of Austin, a mother of two, learned in 2010 that she had multiple myeloma. Following a stem cell transplant and treatment, she has been in remission for 7 years. Shortly after she received her diagnosis, her family decided to live boldly and create experiences together, and they have traveled to 10 countries since. Like others on the team, Schottman said she believes that this trek provides living proof that patients with myeloma are able to live their dreams.

“We are honored to be a part of this ongoing initiative,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of CURE Media Group. “These initiatives have not only played a crucial role in raising funds and awareness but have also raised a sense of hope and optimism among patients, caregivers and doctors.”

“Celgene and the MMRF share an unyielding commitment to improving the lives of patients with multiple myeloma and we are extremely honored to participate in the Moving Mountains for Multiple Myeloma initiative,” said Joel Beetsch, Ph.D., Vice President, Global Patient Advocacy for Celgene. “The progress that has been made over the last decade in this disease is remarkable, however, we recognize that there is work yet to do, and are inspired by the participants in this unique program, which is raising awareness and vital funds for multiple myeloma research.”

To learn more about MM4MM and donate to multiple myeloma research, please visit http://www.movingmountainsformultiplemyeloma.com/iceland18.

About Moving Mountains for Multiple Myeloma

Moving Mountains for Multiple Myeloma (MM4MM) is a collaboration between CURE Media Group and the Multiple Myeloma Research Foundation to raise awareness and funds for myeloma research. This year, Amgen and Celgene Corporation join the effort as sponsors. In addition to Fire and Ice and an earlier Havasu Falls, Arizona, trek, the program will do another trek in 2018: In October, an Amgen-sponsored team will take on Everest Base Camp. To date, MM4MM has raised over $2.0 million for myeloma research and included 34 myeloma patients on 7 climbs. Funds raised go directly to research, supporting the MMRF mission. For more information, visit https://www.themmrf.org/events/.

Multiple myeloma, a cancer of the plasma cell, is the second most common blood cancer. An estimated 30,000 adults will be diagnosed this year, and 12,600 people are predicted to die from the disease.

About the Multiple Myeloma Research Foundation

The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend patients’ lives. Founded in 1998 as a 501(c)(3) nonprofit organization by Kathy Giusti, a patient with multiple myeloma, and her twin sister, Karen Andrews, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF created the only end-to-end solution in precision medicine and the single largest genomic data set in all cancers. As a pioneer and leader at the helm of new research efforts, the MMRF continues to disrupt the industry. Since its inception, the organization has raised more than $400 million and directs nearly 90 percent of the total funds to research and related programs. To learn more, visit www.themmrf.org.

CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com

This hike marks the fifth continent to be visited by a Moving Mountains for Multiple Myeloma team

Moving Mountains for Multiple Myeloma to Hike Through Iceland

CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group’s flagship product, 

® magazine, the nation’s leading consumer digital and print media enterprise focusing on patients with cancer, is kicking off its first-ever social media takeover today, when Moving Mountains for Multiple Myeloma climber April Cooper controls the @curetoday Instagram feed.

“We are excited to launch the first-ever social media takeover for 

®, said Michael J. Hennessy Jr, president of MJH Associates, parent company of 

 Media Group. This takeover will be a behind-the-scenes look, as she’ll be talking about her experience during her mother’s Multiple Myeloma journey, and sharing her climb through photos, videos and Instagram stories.”

Cooper, who is a resident of Dallas, Texas, will be climbing Mount Democrat in Colorado as part of the Multiple Myeloma Research Foundation’s Peak Weekend program and a Moving Mountains for Multiple Myeloma (MM4MM) initiative.

Follow Cooper on her weekend journey as she hikes the Rocky Mountains at 14,158 feet above sea level to honor her mother and to help raise awareness for multiple myeloma.

Follow CURE® on Instagram @curetoday, or follow #CURE or #MM4MM.

CURE Features First-Ever Social Media Takeover

 Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, welcomes Lung Cancer Alliance to its Strategic Alliance Partnership (SAP) Program.

“Countless individuals across the nation are affected by lung cancer,” said Michael J. Hennessy Jr., president of 

 Media Group. “We are proud to partner with Lung Cancer Alliance to continue to empower the lung cancer community through our ongoing efforts to identify novel treatment approaches by providing relevant information.”

Founded in 1995, Lung Cancer Alliance is one of the nation’s leading non-profit health organizations committed to serving the lung cancer community. Lung Cancer Alliance empowers a vibrant and caring community by helping people navigate the paths of early detection, diagnosis, treatment and long-term survival. Lung Cancer Alliance leverages insights into the lung cancer community to improve care, amplify awareness, drive advocacy and lead transformative research with the vision of tripling the number of survivors in the next decade.

Media Group,” said Laurie Fenton Ambrose, President and CEO of Lung Cancer Alliance. “This collaboration will allow us to pursue better outcomes for our community by improving access to resources that patients and loved ones need in their fight against the number one cancer killer no matter where they are in their journey.”

As part of this joint effort, Lung Cancer Alliance will be able to share valuable content through

® magazine, where readers will have access to unprecedented resources including the latest research, interviews and articles that can help patients with cancer, and their caregivers, make better informed decisions. The SAP Program is designed to facilitate an open exchange of information among trusted peers, with the goal to improve patient care.

For more information about the SAP Program, visit https://www.curetoday.com/advocacy/partners.

The partners will collaborate to empower the lung cancer community through educational efforts

CURE Media Group Expands Strategic Alliance Partnership Program with Lung Cancer Alliance

® magazine, the nation’s leading digital and print media enterprise focused on patients with cancer, cancer centers and advocacy groups, is accepting nominations for the 2018 MPN Heroes® awards. This program honors individuals and organizations who have made a difference in the field of rare blood cancers known as myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within the MPN community or a commitment to individual patients.

“We are excited to be accepting nominations for this year’s MPN Heroes Recognition Program. We are proud to recognize another group of exceptional individuals who each and every day make a difference within the MPN community,” said Michael J. Hennessy Jr, president of MJH Associates, parent company of

Nominations are accepted from the community at large. A panel of judges will review the nominations and pick the finalists and winners in two categories: Commitment to the Individual and Commitment to the Broader MPN Community. For more information, to submit a nomination and to learn more about this year’s rules and judges, visit mpnheroes.com.

This year’s winners will be honored at the sixth annual MPN Heroes Celebration Event on November 30 at the Hard Rock in San Diego.

The MPN Heroes Recognition Program is sponsored by Incyte Corporation and

 Media Group to support the program, with 

 hosting the annual MPN Heroes Celebration Event recognizing heroes of the MPN community. Supporting the MPN community is an ongoing effort of Incyte, a global biopharmaceutical company that discovers and develops novel medicines to meet serious unmet medical needs in oncology and other diseases. Individuals or entities supported through funding or directed by Incyte are not eligible for consideration or recognition.

 Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry leading website, CUREtoday.com; innovative video programs, such as 

 Connections®; a series of widely attended live events; and 

® magazine, which reaches over 1 million readers. 

 Media Group is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates Inc. family of businesses, which includes the acclaimed OncLive® (onclive.com) platform of resources for the practicing oncologist. For more information, visit curetoday.com or mjhassoc.com. 

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information, please visit the company’s website at incyte.com.

Follow @Incyte on Twitter at twitter.com/Incyte.

MPN Heroes is a registered trademark of Incyte.

The award recognizes individuals and organizations who are making a difference in the myeloproliferative neoplasm community

Press Releases